Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: It has recently been highlighted that proinflammatory (M1) macrophages predominate over anti-inflammatory (M2) macrophages in obesity, thereby contributing to obesity-induced adipose inflammation and insulin resistance. A recent clinical trial revealed that highly purified eicosapentaenoic acid (EPA) reduces the incidence of major coronary events. In this study, we examined the effect of EPA on M1/M2-like phenotypes of peripheral blood monocytes in obese dyslipidemic patients. RESEARCH DESIGN AND METHODS: Peripheral blood monocytes were prepared from 26 obese patients without and 90 obese patients with dyslipidemia. Of the latter 90 obese patients with dyslipidemia, 82 patients were treated with or without EPA treatment (1.8 g daily) for 3 months. RESULTS: Monocytes in obese patients with dyslipidemia showed a significantly lower expression of interleukin-10 (IL-10), an M2 marker, than those without dyslipidemia. EPA significantly increased serum IL-10 and EPA levels, the EPA/arachidonic acid (AA) ratio, and monocyte IL-10 expression and decreased the pulse wave velocity (PWV), an index of arterial stiffness, compared with the control group. After EPA treatment, the serum EPA/AA ratio was significantly correlated with monocyte IL-10 expression. Only increases in monocyte IL-10 expression and serum adiponectin were independent determinants of a decreased PWV by EPA. Furthermore, EPA significantly increased the expression and secretion of IL-10 in human monocytic THP-1 cells through a peroxisome proliferator–activated receptor (PPAR)γ-dependent pathway. CONCLUSIONS: This study is the first to show that EPA increases the monocyte IL-10 expression in parallel with decrease of arterial stiffness, which may contribute to the antiatherogenic effect of EPA in obese dyslipidemic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002) · Circulation · doi:10.1161/01.cir.0000038493.65177.94 · Cited by 3,707
Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107 · cited 1×
“Moreover, PPARg expression itself has been reported to be significantly associated with increasedM2 monocytes in the vasculature and maturation of alternatively activated macrophages (6,8).”
Suganami, T., Nishida, J., & Ogawa, Y. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000183883.72263.13 · Cited by 1,056 · cited 1×
“The monocyte–macrophage system plays a role in the pathogenesis of obesity and atherosclerotic disease (1,2).”
Self-citationPolyunsaturated fatty acids and inflammatory processes: New twists in an old tale
Calder, P. C. (2009) · Biochimie · doi:10.1016/j.biochi.2009.01.008 · Cited by 721 · cited 3×
“EPA can be metabolized to anti-inflammatory eicosanoids and also partially replace the AA in cell membranes and competitively inhibits the production of AA and inflammatory eicosanoids, thereby exerting an anti-inflammatory effect (20).”
InfluentialAdiponectin Promotes Macrophage Polarization toward an Anti-inflammatory Phenotype
Ohashi, K., Parker, J. L., Ouchi, N., Higuchi, A., Vita, J. A., Gokce, N., Pedersen, A. A., Kalthoff, C., Tullin, S., Sams, A., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088708 · Cited by 646 · cited 1×
“(39) reported that adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype, whichmay be partly linked to the decrease of arterial stiffness in our study.”
Saito, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.003 · Cited by 316 · cited 2×
“National Cholesterol Education ProgramAdult Treatment Panel III (24), as described previously (25).”
Villalta, S. A., Rinaldi, C., Deng, B., Liu, G., Fedor, B., & Tidball, J. G. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq523 · Cited by 299 · cited 1×
“IL-10 has also been reported to promote the differentiation of M2 macrophages and attenuate the M1 macrophage population (30).”
Yamada, H., Yoshida, M., Nakano, Y., Suganami, T., Satoh, N., Mita, T., Azuma, K., Itoh, M., Yamamoto, Y., Kamei, Y., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.171736 · Cited by 112 · cited 1×
“We also reported that EPA markedly inhibits LPS-induced monocyte adhesion to the aortic endothelium in parallel with the suppression of endothelial adhesion molecules intracellular adhesion molecule-1 and vascular cell adhesion molecule-1 (17).”
Self-citation
Research works printed but not linked: 30
- Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J Clin Invest, 112, 1796, 10.1172/JCI200319246 · DOI · Paper page
- Gordon, 2005, Monocyte and macrophage heterogeneity, Nat Rev Immunol, 5, 953, 10.1038/nri1733 · DOI · Paper page
- Lumeng, 2007, Obesity induces a phenotypic switch in adipose tissue macrophage polarization, J Clin Invest, 117, 175, 10.1172/JCI29881 · DOI · Paper page
- Lumeng, 2008, Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes, Diabetes, 57, 3239, 10.2337/db08-0872 · DOI · Paper page
- Swirski, 2009, Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis, Arterioscler Thromb Vasc Biol, 29, 1424, 10.1161/ATVBAHA.108.180521 · DOI · Paper page
- Bouhlel, 2007, PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties, Cell Metab, 6, 137, 10.1016/j.cmet.2007.06.010 · DOI · Paper page
- Ghanim, 2004, Circulating mononuclear cells in the obese are in a proinflammatory state, Circulation, 110, 1564, 10.1161/01.CIR.0000142055.53122.FA · DOI · Paper page
- Satoh, 2010, Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone, Diabetes Care, 33, e7, 10.2337/dc09-1315 · DOI · Paper page
- Fujisaka, 2009, Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice, Diabetes, 58, 2574, 10.2337/db08-1475 · DOI · Paper page
- Yokoyama, 2007, Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis, Lancet, 369, 1090, 10.1016/S0140-6736(07)60527-3 · DOI · Paper page
- Satoh, 2007, Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome, Diabetes Care, 30, 144, 10.2337/dc06-1179 · DOI · Paper page
- Itoh, 2007, Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects, Arterioscler Thromb Vasc Biol, 27, 1918, 10.1161/ATVBAHA.106.136853 · DOI · Paper page
- Satoh, 2009, Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome, Hypertens Res, 32, 1004, 10.1038/hr.2009.145 · DOI
- Renier, 1993, Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice. Modulation of macrophage secretory activities, Arterioscler Thromb, 13, 1515, 10.1161/01.ATV.13.10.1515 · DOI · Paper page
- Michaud, 2001, Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: potential role of PPARs, Diabetes, 50, 660, 10.2337/diabetes.50.3.660 · DOI · Paper page
- Ueeda, 2008, Serum N-3 polyunsaturated fatty acid levels correlate with the extent of coronary plaques and calcifications in patients with acute myocardial infarction, Circ J, 72, 1836, 10.1253/circj.CJ-08-0249 · DOI
- Matsuzaki, 2009, Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease, Circ J, 73, 1283, 10.1253/circj.CJ-08-1197 · DOI · Paper page
- Satoh, 2008, Evaluation of the cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome, Hypertens Res, 31, 1921, 10.1291/hypres.31.1921 · DOI · Paper page
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 2001, Expert Panel on detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 · DOI · Paper page
- Manigrasso, 2005, Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss, J Clin Endocrinol Metab, 90, 5876, 10.1210/jc.2005-0281 · DOI
- Esposito, 2003, Association of low interleukin-10 levels with the metabolic syndrome in obese women, J Clin Endocrinol Metab, 88, 1055, 10.1210/jc.2002-021437 · DOI · Paper page
- Pinderski Oslund, 1999, Interleukin-10 blocks atherosclerotic events in vitro and in vivo, Arterioscler Thromb Vasc Biol, 19, 2847, 10.1161/01.ATV.19.12.2847 · DOI · Paper page
- Namiki, 2004, Intramuscular gene transfer of interleukin-10 cDNA reduces atherosclerosis in apolipoprotein E-knockout mice, Atherosclerosis, 172, 21, 10.1016/j.atherosclerosis.2003.08.032 · DOI
- Han, 2010, Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice, FASEB J, 24, 2869, 10.1096/fj.09-148155 · DOI · Paper page
- Kawashima, 2008, Eicosapentaenoic acid inhibits interleukin-6 production in interleukin-1beta-stimulated C6 glioma cells through peroxisome proliferator-activated receptor-gamma, Prostaglandins Leukot Essent Fatty Acids, 79, 59, 10.1016/j.plefa.2008.07.002 · DOI
- Thompson, 2007, Interleukin-10 is upregulated by nanomolar rosiglitazone treatment of mature dendritic cells and human CD4+ T cells, Cytokine, 39, 184, 10.1016/j.cyto.2007.07.191 · DOI
- Matsumoto, 2008, Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice, Atherosclerosis, 197, 524, 10.1016/j.atherosclerosis.2007.07.023 · DOI
- Tishinsky, 2011, Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPARγ-dependent manner in human adipocytes, Obesity (Silver Spring), 19, 262, 10.1038/oby.2010.186 · DOI · Paper page
- Kumada, 2004, Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages, Circulation, 109, 2046, 10.1161/01.CIR.0000127953.98131.ED · DOI · Paper page
- Lee, 2009, Blood eicosapentaenoic acid and docosahexaenoic acid as predictors of all-cause mortality in patients with acute myocardial infarction—data from Infarction Prognosis Study (IPS) Registry, Circ J, 73, 2250, 10.1253/circj.CJ-09-0327 · DOI · Paper page
Cited by
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
Mason, R. P., Libby, P., & Bhatt, D. L. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313286 · Cited by 407
Obesity and ageing: Two sides of the same coin
Tam, B. T., Morais, J. A., & Santosa, S. (2020) · Obesity Reviews · doi:10.1111/obr.12991 · Cited by 253
Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management
Ganda, O. P., Bhatt, D. L., Mason, R. P., Miller, M., & Boden, W. E. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.061 · Cited by 195
“In mice and humans, EPA has also been shown to increase adiponectin, an insulinsensitizing adipokine (60,61).”
BackgroundBorow, K. M., Nelson, J. R., & Mason, R. P. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.035 · Cited by 175
Preston Mason, R. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0762-1 · Cited by 129
Metadata
- Authors
- Satoh-Asahara, N., Shimatsu, A., Sasaki, Y., Nakaoka, H., Himeno, A., Tochiya, M., Kono, S., Takaya, T., Ono, K., Wada, H., Suganami, T., Hasegawa, K., & Ogawa, Y.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-11-14
- Volume
- 35
- Issue
- 12
- Pages
- 2631-2639
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2114867133
- Cited by
- 64
- References
- 9
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. https://app.cochat.ai/papers/10.2337/dc12-0269
- The paper
- Satoh-Asahara, N., Shimatsu, A., Sasaki, Y., Nakaoka, H., Himeno, A., Tochiya, M., Kono, S., Takaya, T., Ono, K., Wada, H., Suganami, T., Hasegawa, K., & Ogawa, Y. (2012). Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care. https://doi.org/10.2337/dc12-0269
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.